RenovoRx Inc (RNXT)

7.04 -0.04  -0.56% NASDAQ Dec 1, 16:00 7.00 -0.04  -0.57% After-Hours: 20:00 USD
View Full Chart
Price Chart
View All RNXT News

News

View All Events

Events

Date Type Description
02/28/2022 Earnings Results Q4 2021 Earnings Results
11/15/2021 Earnings Results Q3 2021 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: RenovoRx Inc is a clinical-stage biopharmaceutical company. It is focused on developing therapies for the local treatment of solid tumors and conducting a Phase 3 registrational trial for lead product candidate RenovoGem.
  • URL: https://www.renovorx.com
  • Investor Relations URL: https://renovorx.com/investors/
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: N/A
  • Next Earnings Release: Feb. 28, 2022
  • Last Earnings Release: Nov. 15, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.